PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Potassium Chloride→

Potassium Chloride PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
7447-40-7
Molecular formula
KCl
Molecular weight
74.551 g/mol
Drug class
Potassium saltelectrolyte replacement agent
Mechanism of action
Dissociates to provide potassium ions required for resting membrane potential, neuromuscular transmission and normal cardiac conduction. Replacement corrects potassium depletion but does not directly treat the underlying cause of hypokalaemia.
Indications / reported uses
  • Prevention and treatment of hypokalaemia in patients who cannot obtain adequate potassium from diet or oral supplements, including oral and intravenous formulations; dose, route and rate depend on serum potassium and renal function

Sources: US DailyMed — Potassium chloride oral and injection products · NHS — Potassium supplements · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Potassium Chloride PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Potassium Chloride Permitted Daily Exposure (PDE) report (the Potassium Chloride PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Potassium Chloride Occupational Exposure Limit (OEL) report (the Potassium Chloride OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.